Chapter/Section Purchase

1 Study Coverage
1.1 Tyrosine Protein Kinase JAK1 Product Introduction
1.2 Market by Type
1.2.1 Global Tyrosine Protein Kinase JAK1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AZD-4205
1.2.3 Baricitinib
1.2.4 Cerdulatinib
1.2.5 CJ-15314
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tyrosine Protein Kinase JAK1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cutaneous Lupus Erythematosus
1.3.3 Eosinophilia
1.3.4 Hairy Cell Leukemia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tyrosine Protein Kinase JAK1 Sales Estimates and Forecasts 2017-2028
2.2 Global Tyrosine Protein Kinase JAK1 Revenue Estimates and Forecasts 2017-2028
2.3 Global Tyrosine Protein Kinase JAK1 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tyrosine Protein Kinase JAK1 Sales by Region
2.4.1 Global Tyrosine Protein Kinase JAK1 Sales by Region (2017-2022)
2.4.2 Global Sales Tyrosine Protein Kinase JAK1 by Region (2023-2028)
2.5 Global Tyrosine Protein Kinase JAK1 Revenue by Region
2.5.1 Global Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2022)
2.5.2 Global Tyrosine Protein Kinase JAK1 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tyrosine Protein Kinase JAK1 Sales by Manufacturers
3.1.1 Global Top Tyrosine Protein Kinase JAK1 Manufacturers by Sales (2017-2022)
3.1.2 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tyrosine Protein Kinase JAK1 in 2021
3.2 Global Tyrosine Protein Kinase JAK1 Revenue by Manufacturers
3.2.1 Global Tyrosine Protein Kinase JAK1 Revenue by Manufacturers (2017-2022)
3.2.2 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tyrosine Protein Kinase JAK1 Revenue in 2021
3.3 Global Tyrosine Protein Kinase JAK1 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tyrosine Protein Kinase JAK1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tyrosine Protein Kinase JAK1 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tyrosine Protein Kinase JAK1 Sales by Type
4.1.1 Global Tyrosine Protein Kinase JAK1 Historical Sales by Type (2017-2022)
4.1.2 Global Tyrosine Protein Kinase JAK1 Forecasted Sales by Type (2023-2028)
4.1.3 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2028)
4.2 Global Tyrosine Protein Kinase JAK1 Revenue by Type
4.2.1 Global Tyrosine Protein Kinase JAK1 Historical Revenue by Type (2017-2022)
4.2.2 Global Tyrosine Protein Kinase JAK1 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2017-2028)
4.3 Global Tyrosine Protein Kinase JAK1 Price by Type
4.3.1 Global Tyrosine Protein Kinase JAK1 Price by Type (2017-2022)
4.3.2 Global Tyrosine Protein Kinase JAK1 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tyrosine Protein Kinase JAK1 Sales by Application
5.1.1 Global Tyrosine Protein Kinase JAK1 Historical Sales by Application (2017-2022)
5.1.2 Global Tyrosine Protein Kinase JAK1 Forecasted Sales by Application (2023-2028)
5.1.3 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2028)
5.2 Global Tyrosine Protein Kinase JAK1 Revenue by Application
5.2.1 Global Tyrosine Protein Kinase JAK1 Historical Revenue by Application (2017-2022)
5.2.2 Global Tyrosine Protein Kinase JAK1 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2017-2028)
5.3 Global Tyrosine Protein Kinase JAK1 Price by Application
5.3.1 Global Tyrosine Protein Kinase JAK1 Price by Application (2017-2022)
5.3.2 Global Tyrosine Protein Kinase JAK1 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tyrosine Protein Kinase JAK1 Market Size by Type
6.1.1 North America Tyrosine Protein Kinase JAK1 Sales by Type (2017-2028)
6.1.2 North America Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2028)
6.2 North America Tyrosine Protein Kinase JAK1 Market Size by Application
6.2.1 North America Tyrosine Protein Kinase JAK1 Sales by Application (2017-2028)
6.2.2 North America Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2028)
6.3 North America Tyrosine Protein Kinase JAK1 Market Size by Country
6.3.1 North America Tyrosine Protein Kinase JAK1 Sales by Country (2017-2028)
6.3.2 North America Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tyrosine Protein Kinase JAK1 Market Size by Type
7.1.1 Europe Tyrosine Protein Kinase JAK1 Sales by Type (2017-2028)
7.1.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2028)
7.2 Europe Tyrosine Protein Kinase JAK1 Market Size by Application
7.2.1 Europe Tyrosine Protein Kinase JAK1 Sales by Application (2017-2028)
7.2.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2028)
7.3 Europe Tyrosine Protein Kinase JAK1 Market Size by Country
7.3.1 Europe Tyrosine Protein Kinase JAK1 Sales by Country (2017-2028)
7.3.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tyrosine Protein Kinase JAK1 Market Size by Type
8.1.1 Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Type (2017-2028)
8.1.2 Asia Pacific Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2028)
8.2 Asia Pacific Tyrosine Protein Kinase JAK1 Market Size by Application
8.2.1 Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Application (2017-2028)
8.2.2 Asia Pacific Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2028)
8.3 Asia Pacific Tyrosine Protein Kinase JAK1 Market Size by Region
8.3.1 Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Region (2017-2028)
8.3.2 Asia Pacific Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tyrosine Protein Kinase JAK1 Market Size by Type
9.1.1 Latin America Tyrosine Protein Kinase JAK1 Sales by Type (2017-2028)
9.1.2 Latin America Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2028)
9.2 Latin America Tyrosine Protein Kinase JAK1 Market Size by Application
9.2.1 Latin America Tyrosine Protein Kinase JAK1 Sales by Application (2017-2028)
9.2.2 Latin America Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2028)
9.3 Latin America Tyrosine Protein Kinase JAK1 Market Size by Country
9.3.1 Latin America Tyrosine Protein Kinase JAK1 Sales by Country (2017-2028)
9.3.2 Latin America Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Type
10.1.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2028)
10.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Application
10.2.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2028)
10.3 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Country
10.3.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Overview
11.1.3 AbbVie Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc Recent Developments
11.2 Aclaris Therapeutics Inc
11.2.1 Aclaris Therapeutics Inc Corporation Information
11.2.2 Aclaris Therapeutics Inc Overview
11.2.3 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aclaris Therapeutics Inc Recent Developments
11.3 Astellas Pharma Inc
11.3.1 Astellas Pharma Inc Corporation Information
11.3.2 Astellas Pharma Inc Overview
11.3.3 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Astellas Pharma Inc Recent Developments
11.4 AstraZeneca Plc
11.4.1 AstraZeneca Plc Corporation Information
11.4.2 AstraZeneca Plc Overview
11.4.3 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Plc Recent Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Corporation Information
11.5.2 Bristol-Myers Squibb Co Overview
11.5.3 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Co Recent Developments
11.6 Chipscreen Biosciences Ltd
11.6.1 Chipscreen Biosciences Ltd Corporation Information
11.6.2 Chipscreen Biosciences Ltd Overview
11.6.3 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Chipscreen Biosciences Ltd Recent Developments
11.7 CJ HealthCare Corp
11.7.1 CJ HealthCare Corp Corporation Information
11.7.2 CJ HealthCare Corp Overview
11.7.3 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CJ HealthCare Corp Recent Developments
11.8 Concert Pharmaceuticals Inc
11.8.1 Concert Pharmaceuticals Inc Corporation Information
11.8.2 Concert Pharmaceuticals Inc Overview
11.8.3 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Concert Pharmaceuticals Inc Recent Developments
11.9 Eli Lilly and Co
11.9.1 Eli Lilly and Co Corporation Information
11.9.2 Eli Lilly and Co Overview
11.9.3 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly and Co Recent Developments
11.10 Galapagos NV
11.10.1 Galapagos NV Corporation Information
11.10.2 Galapagos NV Overview
11.10.3 Galapagos NV Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Galapagos NV Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Galapagos NV Recent Developments
11.11 Incyte Corp
11.11.1 Incyte Corp Corporation Information
11.11.2 Incyte Corp Overview
11.11.3 Incyte Corp Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Incyte Corp Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Incyte Corp Recent Developments
11.12 Japan Tobacco Inc
11.12.1 Japan Tobacco Inc Corporation Information
11.12.2 Japan Tobacco Inc Overview
11.12.3 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Japan Tobacco Inc Recent Developments
11.13 Jiangsu Hengrui Medicine Co Ltd
11.13.1 Jiangsu Hengrui Medicine Co Ltd Corporation Information
11.13.2 Jiangsu Hengrui Medicine Co Ltd Overview
11.13.3 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
11.14 Nissan Chemical Industries Ltd
11.14.1 Nissan Chemical Industries Ltd Corporation Information
11.14.2 Nissan Chemical Industries Ltd Overview
11.14.3 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nissan Chemical Industries Ltd Recent Developments
11.15 Pfizer Inc
11.15.1 Pfizer Inc Corporation Information
11.15.2 Pfizer Inc Overview
11.15.3 Pfizer Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Pfizer Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pfizer Inc Recent Developments
11.16 Portola Pharmaceuticals Inc
11.16.1 Portola Pharmaceuticals Inc Corporation Information
11.16.2 Portola Pharmaceuticals Inc Overview
11.16.3 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Portola Pharmaceuticals Inc Recent Developments
11.17 Sareum Holdings Plc
11.17.1 Sareum Holdings Plc Corporation Information
11.17.2 Sareum Holdings Plc Overview
11.17.3 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sareum Holdings Plc Recent Developments
11.18 Theravance Biopharma Inc
11.18.1 Theravance Biopharma Inc Corporation Information
11.18.2 Theravance Biopharma Inc Overview
11.18.3 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Theravance Biopharma Inc Recent Developments
11.19 Vectura Group Plc
11.19.1 Vectura Group Plc Corporation Information
11.19.2 Vectura Group Plc Overview
11.19.3 Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Vectura Group Plc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tyrosine Protein Kinase JAK1 Industry Chain Analysis
12.2 Tyrosine Protein Kinase JAK1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tyrosine Protein Kinase JAK1 Production Mode & Process
12.4 Tyrosine Protein Kinase JAK1 Sales and Marketing
12.4.1 Tyrosine Protein Kinase JAK1 Sales Channels
12.4.2 Tyrosine Protein Kinase JAK1 Distributors
12.5 Tyrosine Protein Kinase JAK1 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tyrosine Protein Kinase JAK1 Industry Trends
13.2 Tyrosine Protein Kinase JAK1 Market Drivers
13.3 Tyrosine Protein Kinase JAK1 Market Challenges
13.4 Tyrosine Protein Kinase JAK1 Market Restraints
14 Key Findings in The Global Tyrosine Protein Kinase JAK1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer